| Bioactivity | Compound C108 is a G3BP2 inhibitor. Compound C108 also targeted stress granule-associated proteins and Gtpase-activating protein (SH3 domain) binding protein 2. Compound C108 potently inhibits esophageal squamous cell carcinoma (ESCC) cell metastasis[1][2]. |
| Target | G3BP2 |
| Invitro | Compound C108 (1 μM; 24 h) 对 BT474 细胞具有抗肿瘤活性[1]。Compound C108 (4 μM; 24 h) 显著降低过表达 G3BP2 的 KYSE410 细胞和转染 LINC01554的 KYSE30 细胞中 G3BP2 蛋白的表达[2]。Compound C108 (4 μM; 24 h) 减弱 KYSE410、KYSE30 和 KYSE150 细胞的 ESCC 细胞转移、迁移和侵袭[2]。 Western Blot Analysis[2] Cell Line: |
| In Vivo | Compound C108 (1 μM; 24 h) 靶向并减少肿瘤起始细胞 (TICs)，当把 Compound C108 处理过的 BT-474 细胞注射到雌性非肥胖糖尿病/严重联合免疫缺陷 (NOD-SCID) 小鼠的乳腺脂肪垫中，进行有限稀释异种移植试验时，Compound C108 导致肿瘤起始细胞 (TICs) 数目降低[1]。 |
| Name | Compound C108 |
| CAS | 15533-09-2 |
| Formula | C15H14N2O3 |
| Molar Mass | 270.28 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Gupta N, et al. Stress granule-associated protein G3BP2 regulates breast tumor initiation. Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1033-1038. [2]. Zheng Y, et al. G3BP2 regulated by the lncRNA LINC01554 facilitates esophageal squamous cell carcinoma metastasis through stabilizing HDGF transcript. Oncogene. 2022 Jan;41(4):515-526. |
Compound C108
CAS: 15533-09-2 F: C15H14N2O3 W: 270.28
Compound C108 is a G3BP2 inhibitor. Compound C108 also targeted stress granule-associated proteins and Gtpase-activating
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.